Pays: Australie
Langue: anglais
Source: Department of Health (Therapeutic Goods Administration)
sugammadex sodium, Quantity: 217.6 mg (Equivalent: sugammadex, Qty 200 mg)
Teva Pharma Australia Pty Ltd
Injection, solution
Excipient Ingredients: water for injections; sodium hydroxide; hydrochloric acid
Intravenous
10 vials
(S4) Prescription Only Medicine
Reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.
Visual Identification: A clear, colourless to slightly yellow-brown solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius
Registered
2023-03-28
SUGAMMADEX-TEVA S U G A M M A D E X - T E V A V 1 . 0 CONSUMER MEDICINE INFORMATION (CMI) SUMMARY The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. WHY AM I USING SUGAMMADEX-TEVA? SUGAMMADEX-TEVA contains the active ingredient sugammadex (as sodium). SUGAMMADEX-TEVA is used to speed up recovery of your muscles after an operation. For more information, see Section 1. Why am I using SUGAMMADEX-TEVA? in the full CMI. 2. WHAT SHOULD I KNOW BEFORE I USE SUGAMMADEX-TEVA? Do not use if you have ever had an allergic reaction to sugammadex or any of the ingredients listed at the end of the CMI. TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME PREGNANT OR ARE BREASTFEEDING. For more information, see Section 2. What should I know before I use SUGAMMADEX-TEVA? in the full CMI. 3. WHAT IF I AM TAKING OTHER MEDICINES? Some medicines may interfere with SUGAMMADEX-TEVA and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. 4. HOW DO I USE SUGAMMADEX-TEVA? SUGAMMADEX-TEVA is given as a single injection through an intravenous line. The doctor will work out the dose of SUGAMMADEX-TEVA you need based on your weight and how much muscle relaxant is still affecting you. More instructions can be found in Section 4. How do I use SUGAMMADEX-TEVA? in the full CMI. 5. WHAT SHOULD I KNOW WHILE USING SUGAMMADEX-TEVA? DRIVING OR USING MACHINES • Your doctor will tell you when it is safe to drive and operate potentially dangerous machinery. As far as it is known, SUGAMMADEX-TEVA has no effect on alertness or concentration. STORAGE • SUGAMMADEX-TEVA is stored in the hospital according to the storage conditions on the pack. For more information, see Section 5. What should I know while using SUGAMMADEX-TEVA? in the full CMI. 6. ARE THERE ANY SIDE EFFECTS? Like all medicines, SUGAMMADEX-TEVA can cause side effects, but not ev Lire le document complet
Sugammadex-Teva V1.0 1 AUSTRALIAN PRODUCT INFORMATION SUGAMMADEX-TEVA (SUGAMMADEX) SOLUTION FOR INJECTION 1 NAME OF THE MEDICINE Sugammadex (as sodium) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUGAMMADEX-TEVA 200 mg/2 mL solution for injection contains 200 mg sugammadex (as sodium) in 2 mL solution. SUGAMMADEX-TEVA 500 mg/5 mL solution for injection contains 500 mg sugammadex (as sodium) in 5 mL solution. For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM SUGAMMADEX-TEVA 200 mg/2 mL and 500 mg/5 mL are a clear, colourless to slightly yellow-brown solution for injection. The pH is between 7 and 8 and osmolality is between 300 and 500 mOsm/kg. 4 CLINICAL PARTICULARS THERAPEUTIC INDICATIONS Reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older. DOSE AND METHOD OF ADMINISTRATION The use of an appropriate neuromuscular monitoring technique is recommended to monitor the recovery of neuromuscular blockade. Adequacy of the reversal of the neuromuscular block needs to be based on a clinical assessment of the patient and not train-of-four responses alone, unless quantitative (numeric) assessment is made of neuromuscular function. Patients should be monitored for clinical signs of residual blockade (e.g. difficulty maintaining a patent airway, generalised weakness, inadequate ventilatory effort) following cessation of the anaesthetic and extubation. The recommended dose of sugammadex depends on the level of neuromuscular blockadeto be reversed. The recommended dose does not depend on the anaesthetic regimen. ADULTS Sugammadex can be used to reverse different levels of rocuronium or vecuronium-induced neuromuscular blockade: _ROUTINE REVERSAL_ A dose of 4.0 mg/kg sugammadex is recommended if recovery has reached 1 - 2 post-tetanic counts (PTC) Sugammadex-Teva V1.0 2 following rocuronium- or vecuronium-induced blockade. Median time to recovery of the T 4 /T 1 ratio to 0.9 is around 3 minutes (see Section 5.1 PHARMACODYNAMIC PROPERT Lire le document complet